Moxifloxacine Teva

Moxifloxacin, the active ingredient in Moxifloxacine Teva, is a fluoroquinolone presented as an oral tablet for oral use. It treats a range of bacterial infections, including community‑acquired pneumonia, sinusitis, bronchitis exacerbations, skin infections, and intra‑abdominal infections in adult patients.

GNH USA supplies Moxifloxacine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacine Teva is a fluoroquinolone antibacterial indicated for several bacterial infection categories.

Community‑acquired pneumonia: effective treatment of susceptible bacterial pathogens in adults. Acute bacterial sinusitis: eradicates causative organisms to relieve sinus inflammation. Acute exacerbation of chronic bronchitis: reduces bacterial load during flare‑ups. Skin and skin‑structure infections: combats Gram‑positive and Gram‑negative bacteria. Complicated intra‑abdominal infections: aids in controlling mixed bacterial flora.

Moxifloxacine Teva may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Abdominal discomfort - Rash

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation leading to cardiac arrhythmia - Clostridioides difficile‑associated colitis - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Hepatic dysfunction - Peripheral neuropathy

Before prescribing Moxifloxacine Teva, clinicians should consider several safety factors.

Renal impairment: adjust therapy based on renal function. History of tendon disorders: avoid use due to risk of tendon rupture. QT prolongation risk: monitor ECG in patients with cardiac risk factors. Concomitant corticosteroids: increased risk of tendon injury. Pregnancy and lactation: use only if potential benefits outweigh risks. Store at ambient temperature: keep in original packaging, protect from moisture and light.

Moxifloxacine Teva can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Other fluoroquinolones: additive toxicity. - Antacids containing magnesium or aluminum: markedly reduce absorption. - Warfarin: increased anticoagulant effect and bleeding risk.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened risk of central nervous system stimulation. - Theophylline: elevated plasma concentrations. - Cyclosporine: increased cyclosporine levels, requiring dose adjustment.